Artificial Intelligence (AI) Metabolomics Analysis Service — Deep-Learning Peak Curation, In-Silico Annotation and Machine-Learning Biomarker Discovery

AI Metabolomics Analysis — Why Deep Learning Changes the Pipeline

Untargeted metabolomics is powerful, but its standard software pipeline leaves value on the table at four well-known bottlenecks. Automated peak pickers over-detect noise, producing false-positive features that corrupt downstream statistics. Spectral libraries cover only a fraction of the metabolome, so most detected features stay unannotated. Classical statistics handle linear relationships but struggle with the nonlinear, high-dimensional structure of real cohorts. And single-omics correlation analysis cannot connect a metabolite change to its upstream genes or downstream phenotype.

Artificial intelligence (AI) changes each of these. Convolutional neural networks classify true peaks from instrument noise at a level conventional peak-picking thresholds cannot reach. In-silico fragmentation and structure prediction identify metabolites that exist in no spectral library. Random forest, support-vector machines and gradient boosting select the metabolite combinations that actually separate cohorts. Knowledge graphs and graph neural networks link metabolite changes into mechanism networks across omics layers.

The result is a metabolomics analysis pipeline that returns cleaner feature tables, deeper annotation, interpretable predictive models, and a mechanism narrative — not just a list of changed features.

AI Signal Denoising and Deep-Learning Peak Curation

Raw LC-MS data is noisy. Conventional peak-picking algorithms over-detect: they call chromatographic noise, low-intensity irreproducible signals, and misdefined peak boundaries as features, inflating feature tables with false positives. These errors then propagate through alignment, statistics and annotation.

• Deep-learning peak curation — CNN-based classifiers trained on large sets of extracted ion chromatograms distinguish true metabolite signals from instrument noise, with accuracy in the high 90s on benchmark evaluation.
• Baseline correction and alignment — AI-assisted retention-time alignment and drift correction keep features comparable across batches and injection order.
• Cleaner feature tables — the output is a curated feature matrix where noise peaks are removed before statistics, so downstream models see real biology rather than artifacts.
• Reproducibility — fixed, versioned preprocessing means the same raw files give the same curated table, which is what reviewers and collaborators need.

A clean feature table is the foundation of every later step — annotation, modeling and integration all inherit the quality of the matrix they start from. For studies that also need spatial resolution, our spatial metabolomics services apply the same curation workflow to mass spectrometry imaging datasets.

AI Metabolite Identification and In-Silico Structure Annotation

The deepest bottleneck in untargeted metabolomics is the dark metabolome: in a typical study, most detected features are absent from standard spectral libraries. Library matching alone leaves them unannotated. AI in-silico metabolite annotation methods identify these unknowns directly from the mass spectrum.

• Molecular formula from isotope patterns and fragmentation — computational fragmentation trees explain the observed MS/MS spectrum and infer the molecular formula and fragment relationships.
• Structural fingerprint prediction — machine learning predicts the structural features of an unknown molecule from its spectrum, then searches that fingerprint against molecular structure databases such as PubChem.
• Retention-time and CCS prediction — predicted retention time and, where ion mobility is used, collision cross-section (CCS) provide independent orthogonal evidence that supports or refutes candidate structures.
• Confidence-scored annotation — every annotation carries a confidence level, so you know which identifications are high-confidence versus putative.

These approaches, in the class of SIRIUS and CSI:FingerID, achieve identification rates well above library-only workflows and have been applied to resolve unknowns in complex biological samples. For discovery-scale coverage, our untargeted metabolomics service provides the acquisition depth, and AI annotation extends how much of that coverage is actually identified.

AI Biomarker Discovery and Machine-Learning Cohort Mining

With thousands of features and complex cohorts, classical statistics can miss the structure in the data or overfit it. Machine learning metabolomics is designed for exactly this setting — high-dimensional, nonlinear, cohort-scale data.

• Feature selection — random forest, support-vector machines and gradient boosting (including XGBoost) identify the metabolite combinations that best separate phenotypes, ranking features by contribution.
• Cohort stratification — trained classifiers stratify samples into groups and support predictive modeling and sample-level classification for research cohorts.
• Candidate biomarker panels — the top-ranked metabolites are assembled into multi-metabolite panels with ROC analysis and cross-validation.
• Explainable AI — feature-importance and SHAP-style analysis show which metabolites drive each model, so the model is interpretable, not a black box.

Models are validated with proper train/test splits and cross-validation, with results reported transparently. For the complementary statistics and figure work, our metabolomics data analysis service covers classical multivariate analysis; and where candidates move to absolute quantification, our targeted metabolomics service validates them with isotope-labeled standards.

Every candidate panel is stress-tested against overfitting: models are evaluated on held-out test sets, cross-validation and permutation tests, and only features that survive feature-importance and SHAP-style analysis are carried forward. Top-ranked candidates then receive orthogonal validation — isotope-dilution targeted LC-MS/MS absolute quantification against isotope-labeled internal standards — so what the model identifies is confirmed as a real, quantifiable metabolite at the laboratory level, closing the loop between computational discovery and experimental confirmation.

AI Multi-Omics Integration and Mechanism Networks

A metabolite change rarely stands alone. Connecting it to upstream gene expression, protein abundance, microbial composition, and downstream phenotype is where mechanism lives — and where single-omics correlation analysis runs out.

• Knowledge-graph integration — curated biological knowledge from literature and public databases is organized into graphs that connect metabolites, genes, proteins and microbes.
• Graph-based learning — graph neural network methods learn relationships across omics layers that correlation analysis cannot detect, from host-microbiome co-metabolism to metabolic regulation networks.
• Mechanism networks — the output is a network of metabolite–protein–gene–microbe connections with the supporting evidence, ready for interpretation and publication.
• Cohort-scale integration — transcriptomics, proteomics, microbiome and metabolomics from the same or paired cohorts are integrated rather than analyzed in isolation.

The result is a coherent mechanism story — for example, how a microbial metabolite links a gut community to a host pathway — delivered as a publication-grade network. Our integrative metabolome and transcriptome analysis service covers the matched-data workflows this integration builds on.

Why Choose Our AI Metabolomics Service

We built this service around the four stages where standard metabolomics software loses value, and applied AI where it measurably helps — as a working method, not a marketing label.

• AI at the Right Stages
  Deep learning for peak curation and annotation, machine learning for mining and integration; each applied where it changes the outcome.
• Dark-Metabolome Depth
  In-silico identification extends annotation beyond spectral libraries with confidence scoring.
• Cleaner Data First
  Deep-learning denoising removes noise features before any statistics are run.
• Explainable Models
  Feature importance and SHAP-style analysis keep machine-learning models interpretable.
• Reproducible Pipelines
  Versioned preprocessing and model training, so results are audit-ready.
• Analysis-Ready Outputs
  Curated feature matrices, confidence-scored annotations and explainable models delivered in analysis-ready formats.

Available AI Bioinformatics Services — Annotation, Biomarker and Network Modules

Each AI capability is available as a standalone, purchasable service module — scope the one that matches your study, or combine them into an end-to-end pipeline.

• In-Silico Unknown Metabolite Annotation Service — annotates features absent from spectral libraries (the dark metabolome) using fragmentation trees, structural fingerprint prediction and retention-time/CCS scoring, with per-feature confidence levels. For studies where spectral-library coverage is the annotation bottleneck.
• Machine-Learning Candidate Biomarker Discovery — feature selection, cohort stratification and multi-metabolite biomarker panels with cross-validation, ROC analysis and explainable feature importance. For complex, high-dimensional research cohorts.
• AI-Driven Multi-Omics and Co-Metabolism Network Analysis — knowledge-graph and graph-based integration across metabolomics, transcriptomics, proteomics and microbiome data, including host-microbiome co-metabolism networks. For studies connecting metabolites to genes, proteins and microbial communities.

Each module can be purchased independently or combined into a single project. Contact us to scope which module fits your study design.

AI-Augmented Metabolomics Workflow — From Raw Data to Mechanism

Every project runs through a defined, reproducible pipeline where each AI step is applied at the stage it helps most.

Sample Requirements for AI Metabolomics Analysis

Raw data files can also be provided directly for AI analysis when the acquisition is complete and acquisition metadata is documented. We confirm input requirements and study design with you up front, so volumes, replicates and metadata are agreed before analysis begins.

Deliverables — Curated Features, Annotated Tables and Explainable Models

Each project delivers an audit-ready AI analysis package:

• Curated feature matrix — post-AI-denoising, with QC annotations
• Annotated metabolite table — confidence levels and supporting evidence
• Machine-learning models — with performance metrics (ROC, cross-validation)
• Candidate biomarker panels — and cohort stratification results
• Multi-omics integration networks — with evidence annotations
• Full QC report — preprocessing, model validation, reproducibility
• Written biological interpretation — linking findings to mechanism hypotheses

Every model output, annotation and network edge is traceable to its source data. Where cohort-scale statistics or custom visualization are needed, our metabolomics data analysis team extends the core package.

End-to-End Deep Learning Turns Raw LC-MS Data into Disease-Specific Metabolic Profiles

---

---

Background

Conventional untargeted metabolomics runs through a stepwise pipeline — peak picking, alignment, annotation, then statistics. Each step accumulates its own errors, and features that cannot be matched to a library are simply dropped. A published study set out to remove these bottlenecks by training a deep-learning model to go directly from raw LC-MS data to a biological answer.

Challenge:

Train an end-to-end model that classifies samples and reveals disease-specific metabolic profiles directly from raw LC-MS data, without the error accumulation of stepwise feature extraction.

---

Analytical Approach

The study introduced an end-to-end deep-learning method that takes raw LC-MS data (retention time, m/z, intensity) as input and bypasses conventional peak extraction and metabolite identification entirely. An ensemble of 18 convolutional sub-models (DenseNet121 architecture) was trained on 859 human serum samples spanning three cohorts from separate hospitals — 210 healthy samples, 323 benign lung nodule samples and 326 lung adenocarcinoma samples — and tested on an independent dataset.

---

Key Findings (from the published study)

What this means for your metabolomics program:

• End-to-end AI removes the error accumulation of stepwise pipelines, giving you predictions and insight directly from raw data.
• Features that would be dropped for lack of a library match are used by the model, so no signal is wasted.
• The same approach supports biomarker discovery, cohort stratification and mechanism outputs from a single workflow.
• Inter-hospital batch effects are handled by the model architecture, improving cross-cohort comparability.
• Decision-grade classification and network outputs support go/no-go and mechanism hypotheses in research programs.

Conclusion

This published example shows how end-to-end deep learning transforms raw metabolomics data into classification, biomarker and network insight — the same AI-first philosophy we apply across peak curation, annotation, mining and integration in our service.

Reference

1. Deng, Y., Yao, Y., Wang, Y., Yu, T., Cai, W., Zhou, D., Yin, F., Liu, W., Liu, Y., Xie, C., Guan, J., Hu, Y., Huang, P., Li, W. An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nature Communications 15: 7136 (2024).